METAN, G. Et Al. 2005. Clinical outcomes and therapeutic options of bloodstream infections caused by extended-spectrum beta-lactamase-producing Escherichia coli. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS , vol.26, no.3 , 254-257.

METAN, G., ZARAKOLU, P., Cakir, B., HASCELIK, G., & UZUN, O., (2005). Clinical outcomes and therapeutic options of bloodstream infections caused by extended-spectrum beta-lactamase-producing Escherichia coli. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS , vol.26, no.3, 254-257.

METAN, GÖKHAN Et Al. "Clinical outcomes and therapeutic options of bloodstream infections caused by extended-spectrum beta-lactamase-producing Escherichia coli," INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS , vol.26, no.3, 254-257, 2005

METAN, GÖKHAN Et Al. "Clinical outcomes and therapeutic options of bloodstream infections caused by extended-spectrum beta-lactamase-producing Escherichia coli." INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS , vol.26, no.3, pp.254-257, 2005

METAN, G. Et Al. (2005) . "Clinical outcomes and therapeutic options of bloodstream infections caused by extended-spectrum beta-lactamase-producing Escherichia coli." INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS , vol.26, no.3, pp.254-257.

@article{article, author={GÖKHAN METAN Et Al. }, title={Clinical outcomes and therapeutic options of bloodstream infections caused by extended-spectrum beta-lactamase-producing Escherichia coli}, journal={INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS}, year=2005, pages={254-257} }